{
    "id": 23222,
    "fullName": "TERT over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "TERT over exp indicates an over expression of the Tert protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 7015,
        "geneSymbol": "TERT",
        "terms": [
            "TERT",
            "CMM9",
            "DKCA2",
            "DKCB4",
            "EST2",
            "hEST2",
            "hTRT",
            "PFBMFT1",
            "TCS1",
            "TP2",
            "TRT"
        ]
    },
    "variant": "over exp",
    "createDate": "06/14/2016",
    "updateDate": "06/14/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6862,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Ibrance (palbociclib) inhibited proliferation of a C3 medulloblastoma model cell line over expressing constitutively active AKT1, MYC, hTERT, and dominant negative TP53 in culture (PMID: 27012813).",
            "molecularProfile": {
                "id": 23901,
                "profileName": "AKT1 act mut MYC over exp TERT over exp TP53 inact mut"
            },
            "therapy": {
                "id": 850,
                "therapyName": "Palbociclib",
                "synonyms": null
            },
            "indication": {
                "id": 50902,
                "name": "medulloblastoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5910,
                    "pubMedId": 27012813,
                    "title": "DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27012813"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23901,
            "profileName": "AKT1 act mut MYC over exp TERT over exp TP53 inact mut",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 23902,
            "profileName": "TERT over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}